PAI
Palo Alto Investors Portfolio holdings
AUM
$470M
1-Year Return
2.57%
This Quarter Return
+5.9%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$1.17B
AUM Growth
-$91.9M
(-7.3%)
Cap. Flow
-$96M
Cap. Flow
% of AUM
-8.18%
Top 10 Holdings %
Top 10 Hldgs %
89.35%
Holding
33
New
1
Increased
11
Reduced
5
Closed
4
Top Buys
| 1 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
+$16.2M |
| 2 |
Acadia Pharmaceuticals
ACAD
|
+$11.1M |
| 3 |
Amicus Therapeutics
FOLD
|
+$7.89M |
| 4 |
STAAR Surgical
STAA
|
+$6.95M |
| 5 |
Align Technology
ALGN
|
+$6.39M |
Top Sells
| 1 |
ABMD
Abiomed Inc
ABMD
|
+$121M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
+$9.36M |
| 3 |
Vanda Pharmaceuticals
VNDA
|
+$7.97M |
| 4 |
GRTS
Gritstone bio, Inc. Common Stock
GRTS
|
+$5.74M |
| 5 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$5.32M |
Sector Composition
| 1 | Healthcare | 98.97% |
| 2 | Financials | 1.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALIM
26
DELISTED
Alimera Sciences, Inc.
ALIM
| $544K | 0.05% |
200,919
| – | – |
|
27
Tactile Systems Technology
TCMD
$306M
| $311K | 0.03% |
27,100
| – | – |
|
28
UroGen Pharma
URGN
$891M
| $217K | 0.02% |
24,500
| – | – |
|
29
Gossamer Bio
GOSS
$787M
| $81.9K | 0.01% |
37,750
-1,712,901
| -98% | -$3.72M |
|
30
Dianthus Therapeutics
DNTH
$1.22B
| – | – |
-27,019
| Closed | -$610K |
|
|
MRNS
31
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| – | – |
-31,330
| Closed | -$208K |
|
|
ABMD
32
DELISTED
Abiomed Inc
ABMD
| – | – |
-490,754
| Closed | -$121M |
|
|
CLVS
33
DELISTED
Clovis Oncology, Inc.
CLVS
| – | – |
-4,473,967
| Closed | -$5.32M |
|